世界のドラッグデリバリー（薬物送達）技術市場...市場調査レポートについてご紹介

Table Of Contents

1 Introduction (Page No. – 23)
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
1.5.5 Assumptions

2 Executive Summary (Page No. – 29)

3 Market Overview (Page No. – 34)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Patent Cliff And Increased Competition To Increase Adoption Rate
3.3.1.2 Improving Patient Compliance And Acceptability, An Impetus To The Market
3.3.1.3 Increasing Focus On Pediatric And Geriatric Patients To Boost The Growth
3.3.1.4 Increasing Incidence Of Chronic Diseases To Enhance Demand
3.3.2 Restraints
3.3.2.1 Drug Failures And Recalls Mar Market Growth
3.3.2.2 Technical Barriers Restrict Growth
3.3.3 Opportunities
3.3.3.1 Collaborations Between Pharmaceutical Companies And Drug Delivery Firms
3.3.3.2 Self-Administration And Home Care Drug Delivery Technology
3.3.3.3 Expanding Therapeutic Applications Of Drug Delivery Technology
3.3.4 Targeted Drug Delivery
3.3.4.1 Passive Systems Contribute 60% To The Targeted Market
3.3.4.2 Active Targeted Drug Delivery Has Major Applications In Cancer Therapy
3.3.4.3 Companies Focus On Novel Targeted Drug Delivery
3.3.5 Burning Issues
3.3.5.1 Striking Right Partnerships
3.3.5.2 Improving The Bioavailability Of Drugs
3.4 Regulatory Environment
3.4.1 Stringent Regulations For Pharmaceutical Drugs Across The Globe
3.4.1.1 The Approval Process Is Complex, Time-Consuming, And Expensive
3.4.2 Effect Of The U.S. Healthcare Reforms On The Drug Delivery Industry
3.4.3 Regulations Related To The Approval Of Controlled Release Drugs
3.5 Porter’s Five Forces Analysis
3.6 Value Chain Analysis
3.7 Market Share Analysis
3.7.1 Pulmonary Drug Delivery
3.7.2 Transdermal Drug Delivery
3.7.3 Injectable Drug Delivery
3.7.3.1 Conventional Injection Devices
3.7.3.2 Self-Injection Devices
3.7.4 Implantable Drug Delivery
3.7.5 Other Drug Delivery Segments

4 Global Market, By Technology (Page No. – 61)
4.1 Introduction
4.1.1 Drug Delivery Technology Market Witnessing Technological Advancements
4.2 Opportunity Matrix
4.3 Oral Drug Delivery Technology Market
4.3.1 Big Pharma Companies Establishing In-House Capabilities
4.3.2 Controlled Release
4.3.3 Orodispersible Tablets (ODT) And Taste Masking
4.3.4 Others
4.4 Pulmonary Drug Delivery Technology Market
4.4.1 Therapeutic Applications Of Pulmonary Delivery
4.4.1.1 Application Of Pulmonary Delivery For Non-Respiratory Therapies Is A Growing Opportunity
4.4.2 Metered Dose Inhalers (MDI)
4.4.3 Dry Powder Inhalers (DPI)
4.4.4 Nebulizers
4.5 Transdermal Drug Delivery Technology Market
4.5.1 Passive Transdermal Drug Delivery
4.5.1.1 Matrix System
4.5.1.2 Reservoir System
4.5.2 Active Transdermal Drug Delivery
4.5.2.1 Microporation
4.5.2.2 Iontophoresis
4.5.2.3 Others
4.6 Injectable Drug Delivery
4.6.1 Injectable Drug Delivery Market Witnessing Developments Related To Product Improvement
4.6.2 Conventional Injectable Drug Delivery Technology
4.6.2.1 Low Manufacturing Cost And Affordable Prices: Key Driver For Conventional Injection Devices
4.6.2.2 Fillable
4.6.2.3 Prefilled
4.6.3 Self-Injection Devices
4.6.3.1 Self-Injection Devices Reduce Overall Treatment Cost
4.6.3.2 Pen Injectors
4.6.3.3 Needle-Free Injectors
4.6.3.4 Auto Injectors
4.6.4 Others
4.7 Ocular Drug Delivery Technology Market
4.7.1 Eye Drops
4.7.2 Ointments And Gels
4.7.3 Others
4.8 Nasal Drug Delivery Technology Market
4.8.1 Nasal Drug Delivery Preferred For Locally Acting Drugs And Delivery Of Vaccines
4.8.2 Nasal Sprays
4.8.3 Nasal Inhalers
4.8.4 Nasal Drops
4.8.5 Others
4.9 Topical Drug Delivery Technology Market
4.9.1 Topical Delivery Majorly Adopted For Dermatology Drugs
4.9.2 Semi-Solid Formulations
4.9.3 Liquid Formulations
4.9.4 Solid Formulations
4.10 Implantable Drug Delivery Technology Market
4.10.1 Drug- Eluting Stents
4.10.2 Implantable Infusion Pumps
4.10.2.1 Implantable Infusion Pumps Largely Used For Therapies Of Chronic Ailments
4.10.3 Contraceptive Implants
4.10.4 Intravitreal Implants
4.10.5 Brachytherapy Seeds
4.11 Transmucosal Drug Delivery Technology Market
4.11.1 Oral (Buccal And Sublingual)
4.11.2 Others (Rectal, Vaginal)

5 Geographic Analysis (Page No. – 143)
5.1 Introduction
5.2 North America
5.2.1 Healthcare Reforms In The U.S. Will Impact The Drug Delivery Technology Market
5.3 Europe
5.4 Asia
5.4.1 Booming Pharmaceutical Industry Set To Accelerate The Growth
5.5 Rest Of The World (ROW)

6 Competitive Landscape (Page No. – 190)
6.1 Introduction
6.2 Mergers & Acquisitions
6.3 Agreements, Collaborations, Joint Ventures & Partnerships
6.4 New Product Launch
6.5 Other Developments

7 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 209)
7.1 3m Company
7.2 Alkermes, Inc.
7.3 Aptalis Pharma, Inc.
7.4 Baxter International, Inc.
7.5 Becton, Dickinson And Company
7.6 Catalent Pharma Solutions
7.7 Cima Labs
7.8 Dali Medical Devices
7.9 Endo Health Solutions, Inc.
7.10 Foamix
7.11 Johnson & Johnson, Inc.
7.12 Nektar Therapeutics, Inc.
7.13 Optinose AS
7.14 Psivida Corporation
7.15 Skyepharma PLC
7.16 Tapemark
7.17 The Dow Chemical Company
7.18 Valeant Pharmaceuticals
7.19 Ypsomed Holding AG
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.